NCT00788541View on ClinicalTrials.gov

A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension

PHASE2TerminatedINTERVENTIONAL
Enrollment

197

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Open-Angle GlaucomaOcular Hypertension
Interventions
DRUG

Anecortave Acetate Sterile Suspension, 6 mg/mL

Administered as an injection into an anterior juxtascleral depot

DRUG

Anecortave Acetate Sterile Suspension, 3.75 mg/mL

Administered as an injection into an anterior juxtascleral depot

DRUG

Anecortave Acetate Sterile Suspension, 96 mg/mL

Administered as an injection into an anterior juxtascleral depot

DRUG

Anecortave Acetate Sterile Suspension, 60 mg/ML

Administered as an injection into an anterior juxtascleral depot

OTHER

Anecortave Acetate Vehicle

Administered as an injection into an anterior juxtascleral depot

Trial Locations (1)

76134

Contact Alcon Call Center For Trial Locations, Fort Worth

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00788541 - A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension | Biotech Hunter | Biotech Hunter